SRZN SURROZEN INC
FollowCOMMON STOCK (common), issuer CIK 1824893
66 managers (69 13F filers) reported a position in SRZN shares at 2026-06-30, 10,348,704 shares in all. 27 filers opened a position and 16 filers sold out during the quarter.
- Managers
- 66
- 13F filers
- 69
- New
- 27
- Added
- 19
- Reduced
- 11
- Sold out
- 16
- Shares held by filers
- 10,348,704
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- AI Biotechnology LLC
2,212,556 shares, 9.9% in a 13G/A as of 2026-11-16,0001193125-26-470421
Accepted , ingested - COLUMN GROUP III GP, LP(group Svennilson Peter)
3,813,501 shares, 18.2% in a 13D/A as of 2026-11-16,0001193125-26-467393
Accepted , ingested - Point72 Asset Management, L.P.(group Point72 Asset Management, L.P.)
806,407 shares, 6.9% in a 13G/A as of 2026-09-30,0000919574-26-008110
Accepted , ingested - 5AM Partners VII, LLC (group 5AM Partners VII, LLC)
697,500 shares, 3.9% in a 13G/A as of 2026-09-30,0001873545-26-000012
Accepted , ingested - Boxer Capital Management, LLC(group Boxer Capital Management, LLC)
1,360,683 shares, 11.6% in a 13G/A as of 2026-09-30,0001213900-26-107661
Accepted , ingested - INTEGRATED CORE STRATEGIES (US) LLC
615,730 shares, 3.2% in a 13G/A as of 2026-09-30,0001104659-26-127256
Accepted , ingested - Balyasny Asset Management L.P.(group Balyasny Asset Management)
659,111 shares, 5.61% in a 13G as of 2026-09-30,0001172661-26-005058
Accepted , ingested - STEMPOINT CAPITAL LP(group STEMPOINT CAPITAL LP)
418,527 shares, 3.5% in a 13G/A as of 2026-09-30,0001104659-26-127781
Accepted , ingested - TCG Crossover GP II, LLC (group TCG Crossover GP II, LLC)
0 shares, 0% in a 13G/A as of 2026-09-30,0001193125-26-464080
Accepted , ingested - Commodore Capital LP(group Commodore Capital LP)
885,000 shares, 7.5% in a 13G as of 2026-09-24,0001831942-26-000044
Accepted , ingested
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| COLUMN GROUP III GP, LP10% owner | 2026-10-20 | +517,241 X | $11.6 | Form 4 |
| COLUMN GROUP III GP, LP10% owner | 2026-10-20 | +548,653 X | $11.6 | Form 4 |
| COLUMN GROUP III GP, LP10% owner | 2026-10-20 | +485,830 X | $11.6 | Form 4 |
| Kutzkey Timdirector, 10% owner | 2026-10-20 | +517,241 X | $11.6 | Form 4 |
| Kutzkey Timdirector, 10% owner | 2026-10-20 | +548,653 X | $11.6 | Form 4 |
| Kutzkey Timdirector, 10% owner | 2026-10-20 | +485,830 X | $11.6 | Form 4 |
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
AI Biotechnology LLC and 3 other reporting persons reported 2,212,556 SRZN shares, 9.9% of the class, as of 2026-11-16, in a 13G/A filed 2026-11-20. 0001193125-26-470421
Accepted , ingestedCOLUMN GROUP III GP, LP and 7 other reporting persons reported 3,813,501 SRZN shares, 18.2% of the class, as of 2026-11-16, in a 13D/A filed 2026-11-18. 0001193125-26-467393
Accepted , ingestedTCG Crossover GP II, LLC and 4 other reporting persons reported 0 SRZN shares, 0% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0001193125-26-464080
Accepted , ingested5AM Partners VII, LLC and 3 other reporting persons reported 697,500 SRZN shares, 3.9% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0001873545-26-000012
Accepted , ingestedPoint72 Asset Management, L.P. and 2 other reporting persons reported 806,407 SRZN shares, 6.9% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0000919574-26-008110
Accepted , ingestedSTEMPOINT CAPITAL LP and 2 other reporting persons reported 418,527 SRZN shares, 3.5% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0001104659-26-127781
Accepted , ingestedBalyasny Asset Management L.P. and 4 other reporting persons reported 659,111 SRZN shares, 5.61% of the class, as of 2026-09-30, in a 13G filed 2026-11-16. 0001172661-26-005058
Accepted , ingestedINTEGRATED CORE STRATEGIES (US) LLC and 3 other reporting persons reported 615,730 SRZN shares, 3.2% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-13. 0001104659-26-127256
Accepted , ingestedCOLUMN GROUP III GP, LP and 7 other reporting persons reported 3,813,501 SRZN shares, 21.4% of the class, as of 2026-11-06, in a 13D/A filed 2026-11-06. 0001193125-26-451852
Accepted , ingestedCOLUMN GROUP III GP, LP and 6 other reporting persons acquired 1,551,724 SRZN shares on 2026-10-20, Form 4 filed 2026-10-22. 0001193125-26-429058
Accepted , ingestedCOLUMN GROUP III GP, LP and 7 other reporting persons reported 3,824,612 SRZN shares, 21.5% of the class, as of 2026-10-20, in a 13D/A filed 2026-10-22. 0001193125-26-429027
Accepted , ingestedKutzkey Tim acquired 1,551,724 SRZN shares on 2026-10-20, Form 4 filed 2026-10-22. 0001193125-26-429026
Accepted , ingestedBoxer Capital Management, LLC and 3 other reporting persons reported 1,360,683 SRZN shares, 11.6% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-07. 0001213900-26-107661
Accepted , ingestedCommodore Capital LP and 3 other reporting persons reported 885,000 SRZN shares, 7.5% of the class, as of 2026-09-24, in a 13G filed 2026-10-01. 0001831942-26-000044
Accepted , ingested